Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT.
02 2013, Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Authors: Epelbaum R, Frenkel A, Haddad R, Sikorski N, Strauss LG, Israel O, Dimitrakopoulou-Strauss A
A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.
05 2012, American journal of hematology
Authors: Dann EJ, Blumenfeld Z, Bar-Shalom R, Avivi I, Ben-Shachar M, Goor O, Libster D, Gaitini D, Rowe JM, Epelbaum R
Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
03 2012, International journal of radiation oncology, biology, physics
Authors: Anacak Y, Miller RC, Constantinou N, Mamusa AM, Epelbaum R, Li Y, Calduch AL, Kowalczyk A, Weber DC, Kadish SP, Bese N, Poortmans P, Kamer S, Ozsahin M
Curcumin and gemcitabine in patients with advanced pancreatic cancer.
03 2011, Nutrition and cancer
Authors: Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.
09 2010, Haematologica
Authors: Dann EJ, Bar-Shalom R, Tamir A, Epelbaum R, Avivi I, Ben-Shachar M, Gaitini D, Rowe JM
Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
06 2010, Current medicinal chemistry
Authors: Bar-Sela G, Epelbaum R, Schaffer M
(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.
02 2010, Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Authors: Weiler-Sagie M, Bushelev O, Epelbaum R, Dann EJ, Haim N, Avivi I, Ben-Barak A, Ben-Arie Y, Bar-Shalom R, Israel O
FDG avidity and PET/CT patterns in primary gastric lymphoma.
10 2008, European journal of nuclear medicine and molecular imaging
Authors: Radan L, Fischer D, Bar-Shalom R, Dann EJ, Epelbaum R, Haim N, Gaitini D, Israel O
Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study.
06 2008, BMC cancer
Authors: Jeanneret-Sozzi W, Taghian A, Epelbaum R, Poortmans P, Zwahlen D, Amsler B, Villette S, Belkacémi Y, Nguyen T, Scalliet P, Maingon P, Gutiérrez C, Gastelblum P, Krengli M, Raad RA, Ozsahin M, Mirimanoff RO
The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
03 2008, The American Journal of dermatopathology
Authors: Khamaysi Z, Ben-Arieh Y, Izhak OB, Epelbaum R, Dann EJ, Bergman R
Diagnosis and treatment of primary non-Hodgkin's lymphoma of the parotid gland: a retrospective study - Experience at the Northern Israel Oncology Center (1977-1999).
03 2009, Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Authors: Stein ME, Kuten A, Ben-Shachar M, Drumea K, Zidan J, Gez E, Haim N, Epelbaum R
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
01 2008, Fertility and sterility
Authors: Blumenfeld Z, Avivi I, Eckman A, Epelbaum R, Rowe JM, Dann EJ
Primary lymphoma of the liver: clinical features and outcome of 9 patients.
10 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Authors: Stein ME, Ben-Schacher M, Kuton A, Haim N, Kuten A, Gez E, Zidan J, Siegelmann-Danieli N, Epelbaum R
Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy.
01 2008, Psycho-oncology
Authors: Bar-Sela G, Atid L, Danos S, Gabay N, Epelbaum R
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.
03 2007, Blood
Authors: Dann EJ, Bar-Shalom R, Tamir A, Haim N, Ben-Shachar M, Avivi I, Zuckerman T, Kirschbaum M, Goor O, Libster D, Rowe JM, Epelbaum R
Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma.
01 2007, The American Journal of dermatopathology
Authors: Khamaysi Z, Ben-Arieh Y, Epelbaum R, Bergman R
Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study.
07 2006, International journal of radiation oncology, biology, physics
Authors: Monnard V, Sun A, Epelbaum R, Poortmans P, Miller RC, Verschueren T, Scandolaro L, Villa S, Majno SB, Ostermann S, Ozsahin M, Mirimanoff RO
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma.
09 2005, Human reproduction (Oxford, England)
Authors: Dann EJ, Epelbaum R, Avivi I, Ben Shahar M, Haim N, Rowe JM, Blumenfeld Z
Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?
02 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Authors: Israel O, Mor M, Guralnik L, Hermoni N, Gaitini D, Bar-Shalom R, Keidar Z, Epelbaum R
Primary lymphoma of bone--a retrospective study. Experience at the Northern Israel Oncology Center (1979-2000).
06 2003, Oncology
Authors: Stein ME, Kuten A, Gez E, Rosenblatt KE, Drumea K, Ben-Shachar M, Zidan J, Haim N, Epelbaum R
Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma: comparative study.
07 2003, Radiology
Authors: Bar-Shalom R, Yefremov N, Haim N, Dann EJ, Epelbaum R, Keidar Z, Gaitini D, Frenkel A, Israel O
Excellent long-term survival in patients with early-stage primary bone lymphoma treated with doxorubicin-based chemotherapy and local radiotherapy.
01 2003, American journal of clinical oncology
Authors: Stein ME, Epelbaum R, Zaidan J, Kuten A, Ben-Schachar M, Haim N
Clinicopathologic reassessment of non-mycosis fungoides primary cutaneous lymphomas during 17 years.
03 2003, International journal of dermatology
Authors: Bergman R, Marcus-Farber BS, Manov L, Nerodinisky I, Epelbaum R, Sahar D, Schein-Goldschmid R, Ramon M, Ben-Arieh Y
Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.
11 2002, Journal of surgical oncology
Authors: Epelbaum R, Rosenblatt E, Nasrallah S, Faraggi D, Gaitini D, Mizrahi S, Kuten A
Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
10 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Authors: Israel O, Mekel M, Bar-Shalom R, Epelbaum R, Hermony N, Haim N, Dann EJ, Frenkel A, Ben-Arush M, Gaitini D
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.
08 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Authors: Biganzoli L, Cufer T, Bruning P, Coleman R, Duchateau L, Calvert AH, Gamucci T, Twelves C, Fargeot P, Epelbaum R, Lohrisch C, Piccart MJ
Fertility after treatment for Hodgkin's disease.
12 2002, Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Authors: Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM
Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma.
04 2002, Cancer
Authors: Israel O, Mor M, Epelbaum R, Frenkel A, Haim N, Dann EJ, Gaitini D, Bar-Shalom R, Kolodny GM, Front D
Testimonials
